Matthew Hewitt

Stock Analyst at Craig-Hallum

(2.52)
# 2,088
Out of 4,829 analysts
2
Total ratings
50%
Success rate
26.68%
Average return

Stocks Rated by Matthew Hewitt

Lifecore Biomedical
Nov 22, 2024
Maintains: Buy
Price Target: $8$10
Current: $6.98
Upside: +43.27%